Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis ; volume:42 ; number:2 ; day:21 ; month:3 ; year:2024 ; pages:264-270 ; date:3.2024
Journal of bone and mineral metabolism ; 42, Heft 2 (21.3.2024), 264-270, 3.2024
- Creator
-
Kato, Kazuhiko
Yaginuma, Tatsuhiro
Kobayashi, Arisa
Nakashima, Akio
Ohkido, Ichiro
Yokoo, Takashi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00774-024-01505-7
- URN
-
urn:nbn:de:101:1-2406171035347.556897135907
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kato, Kazuhiko
- Yaginuma, Tatsuhiro
- Kobayashi, Arisa
- Nakashima, Akio
- Ohkido, Ichiro
- Yokoo, Takashi
- SpringerLink (Online service)
Other Objects (12)
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Atypical femur fracture in two patients treated with denosumab: case reports of a patient undergoing maintenance hemodialysis and a kidney transplant recipient, with a literature review of the denosumab used to treat these patients
Daily life of a woman undergoing hemodialysis
Daily life of a woman undergoing hemodialysis
Denosumab and muscle performance
Denosumab: A comprehensive review
Impatto del passaggio da denosumab ad alendronato sui valori di densità minerale ossea
Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study
Bone turnover prediction in patients with chronic kidney disease (CKD) undergoing hemodialysis using shortened dynamic 18F-NaF PET/CT Ki–Patlak
Plasma metabolites and physical function in patients undergoing hemodialysis
Mineral bone disorder and osteoporosis in hemodialysis patients
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Atypical femur fracture in two patients treated with denosumab: case reports of a patient undergoing maintenance hemodialysis and a kidney transplant recipient, with a literature review of the denosumab used to treat these patients
Daily life of a woman undergoing hemodialysis
Daily life of a woman undergoing hemodialysis
Denosumab and muscle performance
Denosumab: A comprehensive review
Impatto del passaggio da denosumab ad alendronato sui valori di densità minerale ossea
Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study
Bone turnover prediction in patients with chronic kidney disease (CKD) undergoing hemodialysis using shortened dynamic 18F-NaF PET/CT Ki–Patlak
Plasma metabolites and physical function in patients undergoing hemodialysis
Mineral bone disorder and osteoporosis in hemodialysis patients
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Atypical femur fracture in two patients treated with denosumab: case reports of a patient undergoing maintenance hemodialysis and a kidney transplant recipient, with a literature review of the denosumab used to treat these patients
Daily life of a woman undergoing hemodialysis
Daily life of a woman undergoing hemodialysis
Denosumab and muscle performance
Denosumab: A comprehensive review
Impatto del passaggio da denosumab ad alendronato sui valori di densità minerale ossea
Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study
Bone turnover prediction in patients with chronic kidney disease (CKD) undergoing hemodialysis using shortened dynamic 18F-NaF PET/CT Ki–Patlak
Plasma metabolites and physical function in patients undergoing hemodialysis